Concepedia

Ellie Corigliano

EC

Statistics

Publications

3

Citations

910

H-Index

3

Active since

2016

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Ellie Corigliano is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, biomarker validation, and cancer immunotherapy.

Publications per year

2016–2025

3

Publications

3

Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer

Karina Kulangara, Nancy R. Zhang, Ellie Corigliano et al. · Archives of Pathology & Laboratory Medicine · 2018 · 536 citations · Full text

, , +17

Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer

Charlotte Roach, Nancy R. Zhang, Ellie Corigliano et al. · Applied immunohistochemistry & molecular morphology · 2016 · 353 citations · Full text

, , +17

Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma

Sandra P. D’Angelo, Mihaela Druta, Brian A. Van Tine et al. · Journal of Clinical Oncology · 2025 · 21 citations · Full text

, , +16

1–3 of 3